Life Science

 

The Yokogawa Life Innovation Business is on the move

Yokogawa has long been committed to the sustainability goals formulated by the UN. In this context, the focus is on good health and well-being. Against this background, the aim is to strengthen the Life Science division in a targeted and sustainable manner in the future.
In order to drive this forward in Europe, Dr. Gerd Heimlich, has now joined Yokogawa as a new a new sales and market developer at Yokogawa Germany, has now assumed responsibility for the Life Innovation Business (LIB). He has worked in the medical device industry for the past 14 years. Prior to that, he was a life science researcher in the field of programmed cell death (apoptosis).
After a first visit to Yokogawa’s global LIB headquarters in Kanazawa, Japan, Dr. Heimlich was available for an interview. Among other things, he talked about the future direction of the Life Innovation Business and the changes that the near future will bring.

Read More

The NAMUR AGM 2016 in 4 min: 650 participants and much, much know-how

This video reviews the NAMUR Annual General Meeting in 4 minutes. Check out, watch the video. Did you enjoyed the NAMUR AGM 2016? What did you like the most? Leave a comment.    

Read More

MD Germany disclose three topics of NAMUR keynote

Andreas Helget, Managing Director of Yokogawa Germany, give insights about NAMUR Annual General Meeting 2016. He says, how Yokogawa Germany is going to extend its business backbone. Would you like to discover more? Ask your questions. Write a comment.

Read More

The path to a new drug

All good things are worth waiting for That would make a great motto for the people who develop new drugs or engage in research on the cell level. The ongoing development of new and ever more effective drugs would be

Read More